Evaluation of the use of sumatriptan–naproxen sodium for menstrual migraine and dysmenorrhea

References

• Wöber C, Brannath W, Schmidt K et al.; PAMINA Study Group. Prospective analysis of factors relate to migraine attacks: the PAMINA study. Cephalalgia27, 304–314 (2007).
   PubMed Web of Science ®Google Scholar
• Leone M, Vila C, McGown C. Influence of trigger factors on the efficacy of almotriptan as early intervention for the treatment of acute migraine in a primary care setting: the START study. Expert Rev. Neurother.10, 1399–1408 (2010).
   PubMed Web of Science ®Google Scholar
• MacGregor EA, Brandes J, Eikermann A et al. Impact of migraine on patients and their families: the Migraine And Zolmitriptan Evaluation (MAZE) survey – Phase III. Curr. Med. Res. Opin.20, 1143–1150 (2004).
   PubMed Web of Science ®Google Scholar
• Martin V, Lipton R. Epidemiology and biology of menstrual migraine. Headache48, S124–S130 (2008).
   PubMed Web of Science ®Google Scholar
• Loder EW, MacGregor EA. Menstrual migraine. In: Migraine in Women. Loder EW, Marcus D (Eds). BC Decker Inc, Ontario, Canada, 102–105 (2004).
   Google Scholar
• Granella F, Sances G, Allais G et al. Characteristics of menstrual and non-menstrual attacks in women with menstrually-related migraine referred to headache centers. Cephalalgia24, 707–716 (2004).
   PubMed Web of Science ®Google Scholar
• MacGregor EA, Victor TW, Hu X et al. Characteristics of menstrual vs nonmenstrual migraine: a post hoc, within-woman analysis of the usual-care phase of a nonrandomized menstrual migraine clinical trial. Headache50, 528–538 (2010).
   PubMed Web of Science ®Google Scholar
• Headache Classification Subcommittee of the International Headache Society (IHS). The International Classification of Headache Disorders: 2nd edition. Cephalalgia24(Suppl. 1), 9–169 (2004).
   PubMed Web of Science ®Google Scholar
• Stewart WF, Lipton RB, Chee E et al. Menstrual cycle and headache in a population sample of migraineurs. Neurology55, 1517–1523 (2000).
   PubMed Web of Science ®Google Scholar
• MacGregor EA, Frith A, Ellis J et al. Incidence of migraine relative to menstrual cycle phases of rising and falling estrogen. Neurology67, 2154–2158 (2006).
   PubMed Web of Science ®Google Scholar
• Couturier EG, Bomhof MA, Neven AK et al. Menstrual migraine in a representative Dutch population sample: prevalence, disability and treatment. Cephalalgia23, 302–308 (2003).
   PubMed Web of Science ®Google Scholar
• Martin VT, Wernke S, Mandell K et al. Defining the relationship between ovarian hormones and migraine headache. Headache45, 1190–1201 (2005).
   PubMed Web of Science ®Google Scholar
• MacGregor A, Hackshaw A. Prevalence of migraine on each day of the natural menstrual cycle. Neurology63, 351–353 (2004).
   PubMed Web of Science ®Google Scholar
• Granella F, Sances G, Messa G et al. Treatment of menstrual migraine. Cephalalgia17, S35–S38 (1997).
   PubMed Web of Science ®Google Scholar
• MacGregor A. Migraine associated with menstruation. Funct. Neurol.15, S143–S153 (2000).
   PubMed Web of Science ®Google Scholar
• Visser WH, Jaspers NM, de Vriend RH et al. Risk factors for headache recurrence after sumatriptan: a study in 366 migraine patients. Cephalalgia16, 264–269 (1996).
   PubMed Web of Science ®Google Scholar
• Dowson AJ, Kilminster SG, Salt R et al. Disability associated with headaches occurring inside and outside the menstrual period in those with migraine: a general practice study. Headache45, 274–282 (2005).
   PubMed Web of Science ®Google Scholar
• Pinkerman B, Holroyd K. Menstrual and nonmenstrual migraines differ in women with menstrually-related migraine. Cephalalgia30, 1187–1194 (2010).
   PubMed Web of Science ®Google Scholar
• Parantainen J, Vapaatalo H, Hokkanen E. Relevance of prostaglandins in migraine. Cephalalgia5(Suppl. 2), 93–97 (1985).
   PubMed Web of Science ®Google Scholar
• Hedman C, Winther K, Knudsen JB. Platelet function in classic migraine during attack-free periods. Acta Neurol. Scand.78(4), 271–277 (1988).
   PubMedGoogle Scholar
• Mezei Z, Kis B, Gecse A et al. Platelet arachidonate cascade of migraineurs in the interictal phase. Platelets11, 222–225 (2000).
   PubMed Web of Science ®Google Scholar
• Nattero G, Allais G, De Lorenzo C et al. Menstrual migraine: new biochemical and psychological aspects. Headache28, 103–107 (1988).
   PubMed Web of Science ®Google Scholar
• Nattero G, Allais G, De Lorenzo C et al. Relevance of prostaglandins in true menstrual migraine. Headache29, 232–237(1989).
   Google Scholar
• Benedetto C. Eicosanoids in primary dysmenorrhea, endometriosis and menstrual migraine. Gynecol. Endocrinol.2, 71–94 (1989).
   Google Scholar
• Nigam S, Benedetto C, Zonca M, Leo-Rossberg I, Lubbert H, Hammerstein J. Increased concentration of eicosanoids and platelet-activating factor in menstrual blood from women with primary dysmenorrhea. Eicosanoids4(3), 137–141 (1991).
   PubMedGoogle Scholar
• Dahl H. Naproxen (Naprosyn) pharmacokinetics: therapeutical relevance and tolerance profile. Cephalalgia6(Suppl. 4), 69–75 (1986).
   PubMedGoogle Scholar
• Welch KMA, Ellis DJ, Keenan PA. Successful migraine prophylaxis with naproxen sodium. Neurology35, 1304–1310 (1985).
   PubMed Web of Science ®Google Scholar
• Durham PL, Vause CV, Derosier F, McDonald S, Cady R, Martin V. Changes in salivary prostaglandin levels during menstrual migraine with associated dysmenorrhea. Headache50, 844–851 (2010).
   PubMed Web of Science ®Google Scholar
• Cady RK, Diamond ML, Diamond MP et al. Sumatriptan–naproxen sodium for menstrual migraine and dysmenorrhea: satisfaction, productivity, and functional disability outcomes. Headache51(5), 664–673 (2011).
   PubMed Web of Science ®Google Scholar
• Mannix LK, Martin VT, Cady RK et al. Combination treatment for menstrual migraine and dysmenorrhea using sumatriptan–naproxen. Two randomized controlled trials. Obstet. Gynecol.114(1), 106–113 (2009).
   PubMed Web of Science ®Google Scholar
• Allais G, Bussone G, Airola G et al. Oral contraceptive-induced menstrual migraine. Clinical aspects and response to frovatriptan. Neurol. Sci.29, S186–S190 (2008).
   PubMedGoogle Scholar
• Suthisisang CC, Poolsup N, Suksomboon N, Lertpipopmetha V, Tepwitukqid B. Meta-analysis of the efficacy and safety of naproxen sodium in the acute treatment of migraine. Headache50(5), 808–818 (2010).
   PubMed Web of Science ®Google Scholar
• Allais G, Castagnoli Gabellari I, De Lorenzo C, Mana O, Benedetto C. Menstrual migraine: clinical and therapeutical aspects. Expert Rev. Neurother.7(9), 1105–1120 (2007).
   PubMed Web of Science ®Google Scholar
• Sances G, Martignoni E, Fioroni L, Blandini F, Facchinetti F, Nappi G. Naproxen sodium in menstrual migraine prophylaxix: a double-blind placebo controlled study. Headache30(11), 705–709 (1990).
   PubMed Web of Science ®Google Scholar
• Marjoribanks J, Proctor M, Farquhar C, Derks RS. Nonsteroidal anti-inflammatory drugs for dysmenorrhea. Cochrane Database Syst. Rev.1, CD001751 (2010).
   PubMed Web of Science ®Google Scholar